Please login to the form below

Not currently logged in

antibiotic resistance

This page shows the latest antibiotic resistance news and features for those working in and with pharma, biotech and healthcare.

Report finds ‘startling’ lack of progress of antibiotic R&D agenda

Report finds ‘startling’ lack of progress of antibiotic R&D agenda

Antimicrobial resistance has become a higher-profile subject and there have been ‘significant advances’ in efforts to cut the use of antibiotics in agriculture. ... However, those advances have mainly happened in high-income countries. Clift also

Latest news

More from news
Approximately 9 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Combining therapies and combining research Combining therapies and combining research

    The strategy for retaining antibiotic security. The World Health Organization recognises antimicrobial resistance (AMR) as one of the most pressing global threats to medicine. ... While resistance developed against streptomycin alone, combination with

  • Rules of engagement Rules of engagement

    countries highlighted people’s unfamiliarity with the language of antibiotic resistance. ... Only one-fifth were aware of its abbreviated form  ‘AMR’. By contrast, more than two-thirds knew of the terms ‘antibiotic resistance’ or ‘drug

  • Significant figures Significant figures

    The company hopes the novel therapy and its delivery method could be a potential game changer in the field of antibiotic resistance. ... European physicians welcome the development of new antibiotics. Key opinion leaders will explain to some extent how

  • A healthy challenge A healthy challenge

    Whether these challenges take the form of antibiotic resistance or obesity, I believe they need to be tackled in a holistic manner.”.

  • The AMR threat The AMR threat

    The scale of the antimicrobial resistance challenge. One of the major public health threats of the modern age, antibiotic resistance can affect anyone, of any age, in any country. ... it”. They added: “Dame Sally is at the forefront of antibiotic

More from intelligence
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...